SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

AGM Trading Update

27 Feb 2026 07:00

RNS Number : 5965U
Gooch & Housego PLC
27 February 2026
 

 

 

27 February 2026

 

Gooch & Housego PLC

("G&H" or the "Company" or the "Group")

 

AGM Trading Update

 

"Strong order book growth strengthens confidence in full year out-turn"

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, will hold its Annual General Meeting at 11.00 a.m. GMT today at the Company's headquarters in Ilminster, Somerset.

 

Since the beginning of the new financial year on 1 October 2025 the Group's order book has grown strongly and is currently at £168.3m (30 September 2025: £142.3m), reflecting a further increase in demand from A&D customers in the US and Europe for G&H's precision optics, optical systems and advanced imaging solutions for military platforms. Demand at Global Photonics and Phoenix Optical, both of which were acquired in FY2025, has been strong.

 

Demand overall in G&H's Industrial markets has improved since the start of the new financial year, and there are encouraging signs that the recovery in semiconductor manufacture is now underway. We continue to expect a sustained recovery in industrial laser and semiconductor markets in the second half of 2026. In Life Sciences, the supply chain challenges referenced in our full year results in December 2025 in connection with 'last time buy' orders for Pockels cells have now been resolved and we expect production to ramp in H2 FY2026 and thus a greater H2 weighting to our FY2026 results than in FY2025.

 

The Group continues to execute on its strategic objectives, which are focused on delivering mid-teen returns on sales in the medium term. We continue to focus on operational improvements, capacity expansion and management of supply chain disruption to ensure we execute successfully on the increased customer demand for our products and photonic solutions. The integration into the Group of Global Photonics and Phoenix Optical, acquired in May 2025 and October 2024 respectively, is progressing to plan. Capacity is being expanded at these two businesses in response to increased demand, within the existing footprint at both sites and in line with the year's expected capital expenditure.

 

The Group's net debt has reduced in the year-to-date. A reduction in working capital, partially offset by capital expenditure and payment of deferred consideration, meant that net debt excluding lease liabilities at the end of January 2026 reduced to £28.0m (Sept 2025: £29.9m).

 

Outlook

 

The Group is strongly positioned in attractive growth markets and continues to make progress in the delivery of its strategy. Despite some uncertainty in the macro-economic environment and potential supply chain constraints, the Group is benefiting from strong growth in its A&D order book and an expanding pipeline of potentially large, multi-year contracts. Meanwhile, the outlook is improving in its other markets, particularly industrial laser and semiconductor. The Board's expectations for the current year remain unchanged, and are underpinned by the order book, self-help measures and new business pipeline, whilst confidence in the medium-term potential of the Group continues to grow.

 

Charlie Peppiatt, Chief Executive Officer of Gooch and Housego, commented:

"The strong order book growth since the start of the new financial year increases our confidence in the Group's full year out-turn. The strategic acquisitions of Global Photonics and Phoenix Optical in FY2025 have delivered strong customer demand, such that capacity at both sites is being increased. We continue to remain focused on operational improvements and, whilst some macro-economic uncertainty remains, we are making good progress in achieving our strategic ambition of delivering mid-teen returns on sales in the medium term."

 

For further information please contact:

 

Charlie Peppiatt, Chief Executive Officer

Gooch & Housego PLC

+44 (0) 1460 256440

 

Mark Court / Sophie Wills / Abigail Gilchrist

G&H@buchanan.uk.com

Burson Buchanan

+44 (0) 20 7466 5000

 

Christopher Baird / David Anderson

Investec Bank plc

+44 (0) 20 7597 5970

 

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGZZVVMGVZM
Date   Source Headline
3rd Jun 20267:00 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim Results
20th May 20267:00 amRNSNotice of Half Year Results
10th Apr 20262:25 pmRNSHolding(s) in Company
9th Apr 20267:00 amRNSHalf Year Trading Update
20th Mar 20263:16 pmRNSHolding(s) in Company
27th Feb 20262:23 pmRNSResult of AGM
27th Feb 20267:00 amRNSAGM Trading Update
2nd Feb 20267:00 amRNSChief Financial Officer appointment date
22nd Jan 20262:26 pmRNSHolding(s) in Company
13th Jan 20264:41 pmRNSHolding(s) in Company
12th Jan 20264:34 pmRNSPDMR notice
12th Jan 20263:30 pmRNSGrant of LTIP awards
9th Jan 20267:00 amRNSPDMR Notice and Issue of Equity
7th Jan 20267:00 amRNSPosting of Annual Report and Notice of AGM
12th Dec 20257:00 amRNSAppointment of Chief Financial Officer
2nd Dec 202511:36 amRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSResults for the year ended 30 September 2025
25th Nov 20257:00 amRNSNotification of Full Year Results
20th Nov 20252:14 pmRNSHolding(s) in Company
4th Nov 20257:07 amRNSDirectorate Update
8th Oct 20257:00 amRNSFurther Issue of Shares and TVR
7th Oct 20257:00 amRNSFull Year Trading Update
1st Oct 20252:15 pmRNSHolding(s) in Company
21st Jul 20257:00 amRNSChief Financial Officer Transition
15th Jul 20255:08 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSNotification of Major Holdings
23rd Jun 20252:30 pmRNSHolding(s) in Company - Replacement
20th Jun 202512:08 pmRNSHolding(s) in Company
18th Jun 20257:00 amRNSCompletion of Acquisition & Total Voting Rights
3rd Jun 20257:00 amRNSInterim Results
20th May 20257:00 amRNSNotification of Half Year Results
14th May 20257:00 amRNSAcquisition of Global Photonics
9th Apr 20252:16 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSHalf Year Trading Update
24th Feb 20252:19 pmRNSResult of AGM
24th Feb 20257:00 amRNSAGM Trading Update
7th Jan 20252:58 pmRNSGrant of LTIP Awards
6th Jan 202511:15 amRNSPosting of Annual Report and Notice of AGM
20th Dec 20243:15 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSResults for the year ended 30 September 2024
4th Nov 20247:00 amRNSNotification of Full Year Results
30th Oct 20247:00 amRNSAcquisition of Phoenix Optical
28th Oct 20242:35 pmRNSHolding(s) in Company
8th Oct 20247:00 amRNSFull Year Trading Update
26th Sep 202410:31 amRNSDirector/PDMR Shareholding
23rd Aug 202412:52 pmRNSNotification of Major Holdings
16th Aug 20245:46 pmRNSHolding(s) in Company
16th Aug 20244:49 pmRNSHolding(s) in Company
15th Aug 20244:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.